Citi acted as financial advisor to the Cell Design Labs in connection with the transaction. Skadden is advising Gilead Sciences, Inc. and its cell therapy subsidiary…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
